chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I was at work felt fine I went to my break and came back from break. I was on the computer I started feeling sweaty and nauseas I threw up and within 30 minutes or a hour I vomited 6 times. I went to the office and the first responder from work gave me fluids and I was still vomiting and started dry heaving. The HR department they contacted rescue squad about 20 mins later they came and took my vitals and I vomited as they were starting my IV. They took me to the ER. I vomited again they checked my blood and they said it was normal. I got a few bags of IV fluids and then I was released. Then I went home and was pushing fluids to hydrate myself. The next day I worked for a friend and I was so tire for the next 3 days.
345PM vax given 345PM pt c/o tiredness & feeling bad;BP 102/77;states was sleep deprived & had not eaten since 6AM -42PM & states light-headed et feeling strange;pallor noted w/decreased alertness;epi given;pt did not go to ER felt better
Fever. Chills. Body aches. Lightheadedness.   Treated with Tylenol. Resolved in approx 30 hours.
Received dose from expired vial; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received dose from expired vial) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047C21A) for COVID-19 vaccination.     No Medical History information was reported.    In November 2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In November 2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received dose from expired vial). In November 2021, EXPIRED PRODUCT ADMINISTERED (Received dose from expired vial) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were reported.   No treatment medication were reported.  The pharmacist administered booster doses of the Moderna COVID-19 vaccine to patients  on 12 Nov 2021, 15 Nov 2021 and 16 Nov 2021. Date the vial was initially stored in the refrigerator was Unknown, Vial has not undergone any temperature excursion. No other further adverse events were reported.   Most recent FOLLOW-UP information incorporated above includes: On 24-Nov-2021: Follow up received contains non-significant information.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. On 29-MAY-2013, the patient was vaccinated with a second dose of expired GARDASIL (Lot number was reported as 0523U, expiry date was 09-FEB-2010), 0.5 milliliter (ml), intramuscularly. The first dose of GARDASIL was administered on 29-MAR-2013. No adverse effect reported. Additional information has been requested.
On the evening of the patient's injection 11/21/00, site became reddened, warm, painful. On 11/22/00, the patient noticed a itchy rash in shoulder area. The rash spread to the neck, trunk and other arm over the next few days. The patient took Benadryl, there was some itching in her throat. She went to the office on 11/27/00 and is now recovering.
89 year old vaccinated male with COPD was admitted for acute respiratory failure caused by Covid-19 pneumonia. He was in renal failure and a fib with RVR also. Despite treatments, his condition worsened and became unresponsive. He was made DNR by family and they have now accepted hospice services. He will be discharged home today with hospice.
pt recv vax 23JAN97 & 31JAN97 pt devel a fever & cough on 2FEB97 pt devel a rash which looked like someone splashed red paint all over the little one;
This spontaneous report was received from a registered nurse referring to unspecified number of patients of unknown ages and genders. On unspecified dates in 2014, doses of VAQTA (Lot# and expired date unspecified) and other vaccines were administered to unspecified patients (doses, frequency and route unspecified), after exposed to temperatures of 10 C degree for 37.5 hours/ temperature excursions on 08-AUG-2014, 13-AUG-2014 and 28-AUG-2014. No adverse effect has been reported. This is of the several reports from the same source. Additional information has been requested.
headache, fever, chills, extreme body aches-very weak, shortness of breathe, swelling on my upper right arm thru armpit and upper right torso area front to back, dizzy, severe shooting pain through my upper back and collar bones  from right to left, and exhaustion
The injection was painful, bled and was black and blue for a month.  Still has a black dot at injection site.  I had pain in my right arm, which at times moves to my left arm, shoulders and neck area.  I am currently going to a Physical Therapy and slowly improving.
Upper arm and shoulder had deep muscle pain for 4 days. Unable to sleep on left side and had restricted range of motion for 3 days. No redness or soreness at injection site. Headache for 2 days. Burning with urination for 1 day.
Information has been received from a 68 year old female consumer with no known allergies or pertinent medical history who on 04-APR-2008 was vaccinated with zoster vaccine live (Oka/Merck). Concomitant therapy included alendronate sodium (MSD), calcium (unspecified) (+) vitamin D (unspecified), vitamins (unspecified), biotin and PROZAC. On 05-APR-2008, the patient experienced tenderness, erythema, pruritus, and warmth at the site of injection after vaccination. The patient reported that the erythema at the injection site "spread to about the size of a top of a can of vegetables." Unspecified medical attention was sought with the pharmacist. There were no lab studies performed. On 08-APR-2008, the patient recovered. There was no product quality complaint involved. Additional information has been requested.
Starting the afternoon of the injection day, took Extra Strength Tylenol every 6 hours Violent chills the night of the injection, around midnight Occasional sinus pain and mild sweaty chills (hot/cold) for the whole day after injection Skin sensitivity all over body for the whole day after injection Body aches, especially rib area pain for the whole day after injection Headache, mostly dull but with occasional stabbing pain the day after injection Dull headache with no stabbing pain the second day after injection Palpitations the whole day after injection, starting in the morning and subsiding two days after injection Mild injection site ache/pain, starting the night of the injection and subsiding two days later
Pt recvd MMR vax 31AUG90; On 09SEP90 pt was hospitalized w/focal encephalitis believed due to herpes virus infect;16OCT90 pt cont to exp bilateral blindness,devel delay,&a stroke synd involving rt side of body;MD didn't attribute exp to vax
Red warm and swollen left deltoid and axilla. Recommended antiinflammatory and Benadryl. Call back if worse for possible antibiotic.
Mild rash on right arm; Pain at the injection site; This case was reported by a physician via sales rep and described the occurrence of injection site pain in a 50-year-old female patient who received Flu Seasonal QIV Dresden (Fluarix Quadrivalent 2019-2020 season) for prophylaxis.   Concomitant products included PARACETAMOL (TYLENOL).   On 4th October 2019, the patient received the 1st dose of Fluarix Quadrivalent 2019-2020 season .5 ml. On 4th October 2019, less than an hour after receiving Fluarix Quadrivalent 2019-2020 season, the patient experienced injection site pain. In October 2019, the patient experienced rash. On an unknown date, the outcome of the injection site pain was recovered/resolved and the outcome of the rash was unknown.   It was unknown if the reporter considered the injection site pain and rash to be related to Fluarix Quadrivalent 2019-2020 season.  Additional details were provided as follows: The patient received the vaccine in left arm. The patient received Fluarix Quadrivalent 2019-2020 season within a few minutes of administration patient complained of pain at injection site the soreness lasted for 3-4 days and she experienced a mild rash on right arm. The patient did mention that she took tylenol prior to receiving the vaccine. This case linked with US2019AMR185904, reported by same reporter.
No pain @ time of insertion. Next day noticed pain with movement of (Rt) shoulder. Continues today (10/26/09) to have pain with any cross over type movement of Rt arm. Pain with dressing, baking, cleaning.
1st day c/o stomach upset-vomited 3-4 days;diarrhea 1wk;craved water;arm swelled, red sensitive to week;soreness left p/1wk;3 days ago c/o soreness in joints & arms like arthritis;muscles sore, numbness from finger tips to elbows;
developed alopecia after receiving the vaccine; This is a spontaneous report received from contactable reporter(s) (Physician) from a sales representative. The reporter is the parent.  A 7-year-old male patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ALOPECIA (non-serious), outcome "unknown", described as "developed alopecia after receiving the vaccine". The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Systemic: Dizziness / Lightheadness-Severe, Systemic: Exhaustion / Lethargy-Severe, Systemic: Fainting / Unresponsive-Medium, Systemic: Flushed / Sweating-Severe
large, red, and warm rash on the same arm but not at the injection site; warm rash on the same arm but not at the injection site; This case was reported by a consumer via call center representative and described the occurrence of red rash in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On 18th October 2020, the patient received Shingrix. On 20th October 2020, 2 days after receiving Shingrix, the patient experienced red rash and skin warm. On an unknown date, the outcome of the red rash and skin warm were unknown.   It was unknown if the reporter considered the red rash and skin warm to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but it was selected as adult as per the vaccine indication. The patient received Shingrix and had large red and warm rash on the same arm but not at the injection site and was away from it near elbow. The reporter asked was that common from the vaccine.
This spontaneous report as received from a medical assistant refers to a 1 year old patient of unknown gender. The patient's drug allergies and pertinent medical history was not reported. On 02-JUL-2014 the patient was vaccinated with first dose of VAQTA (dose, frequency and route of administration were not reported) (lot # J005010, expiry date: 23-OCT-2015) which was stored improperly. No adverse effects were noted. No product quality complaint was reported for VAQTA. This case is linked to 1407USA010956, 1407USA012902, 1407USA012903, 1407USA012904, , 1407USA012905, 1407USA012906, 1407USA012907, 1407USA012908, 1407USA012909, 1407USA012910, 1407USA012911, 1407USA012912, 1407USA012913, 1407USA012914, 1407USA012915, 1407USA012916, 1407USA012917, 1407USA012918, 1407USA012919, 1407USA012920, 1407USA012921, 1407USA012922, 1407USA012923, 1407USA012924, 1407USA012925, 1407USA012926, 1407USA012927, 1407USA012928, 1407USA012929, 1407USA012930, 1407USA012931, 1407USA012932, 1407USA012933, 1407USA012934, 1407USA012935, 1407USA012936, 1407USA012937, 1407USA012938, 1407USA012939, 1407USA012940, 1407USA012941, 1407USA012942, 1407USA012943, 1407USA012944, 1407USA012945, 1407USA012946, 1407USA012947, 1407USA012948, 1407USA012949, 1407USA012950, 1407USA012951, 1407USA012952, 1407USA012953, 1407USA012954, 1407USA012955, 1407USA012956, 1407USA012957, 1407USA012958, 1407USA012959, 1407USA012960, 1407USA012961, 1407USA012962, 1407USA012963, 1407USA012964, 1407USA012965, 1407USA012966, 1407USA012967, 1407USA012968, 1407USA012969, 1407USA012970, 1407USA012971, 1407USA012972, 1407USA012973, 1407USA012974, 1407USA012975, 1407USA012976, 1407USA012977, 1407USA012978, 1407USA012979, 1407USA012980, 1407USA012982, 1407USA012983, 1407USA012984, 1407USA012985, 1407USA012987, 1407USA012988, 1407USA012989, 1407USA012990, 1407USA012991, 1407USA012992, 1407USA012993, 1407USA012994, 1407USA012995, 1407USA012996, 1407USA012997, 1407USA012998, 1407USA012999, 1407USA013000, 1407USA013013 and 1407USA01304 (same reporter link).
PAIN IN THE TERMINAL END OF SPINAL CORD; SWELLING OF THE RIGHT PELVIC LYMPH NODE; This spontaneous report received from a patient concerned a 76 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1805018 expiry: UNKNOWN) dose was not reported, administered on 11-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 23-MAR-2021, the subject experienced swelling of the right pelvic lymph node. On 06-APR-2021, the subject experienced pain in the terminal end of spinal cord. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from pain in the terminal end of spinal cord on APR-2021, and had not recovered from swelling of the right pelvic lymph node. This report was non-serious.
metal taste in mouth; chills; soreness in the area of the vaccine; Her skin had a little chill like as if she went out in the cold and her hair stood up or like she had gotten scared; This is a spontaneous report from a contactable consumer (patient). A 58-year-old female patient received dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number EY18121 or CW0164) via an unspecified route of administration on 17Apr2021 at 08:16 (at the age of 58-years-old) as a single dose in the left arm for COVID-19 immunization. Medical history included fractured her right foot in three places around 2 months ago (as of 18Apr2021) and she has gotten bruises her whole life "and nobody can figure out why." The patient did not receive any other vaccines within 4 weeks prior to the vaccine. Concomitant medications included acetylsalicylic acid, caffeine, paracetamol (EXCEDRIN MIGRAINE) from an unknown date for headaches, calcium and vitamin D from unknown dates (for about a month) because she fractured her right foot. On 17Apr2021 the patient experienced metal taste in mouth, chills, and soreness in the area of the vaccine. An hour and a half after getting the shot (also reported as an hour after) she had a metal taste in her mouth. She ate something and then got a chill. Her skin had a little chill like as if she went out in the cold and her hair stood up or like she had gotten scared. She took a nap and woke up 3 hours later and it was gone. She does not know how long the metal taste went on for. She still had a little taste and it was still a little bit bitter or something. She did not know if it was that or if it was from what she ate. She knows that yesterday (18Apr2021) she did not have this taste. She did not know how long it lasted for the first day because she went to sleep.  She thought she did have the taste Saturday(17Apr2021). It was "like metal when you take iron pills that taste like that."  There was soreness in the area on Saturday (17Apr2021) and Sunday (18Apr2021).  It was right away. Today it was fine.  If she touched it now, there was very little soreness. The patient did not receive any treatment for the events. The outcomes of metal taste was unknown. The outcome of soreness in the area of the vaccine was recovering. The outcome of chills was recovered.  No follow-up attempts are needed. No further information is expected.
She was hallucinating/having auditory hallucinations; She had a fever of 102.9; Headache; pain in her stomach and in her side; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 17-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 15Aug2023 as dose number unknown, single (Batch/Lot number: unknown) at the age of 17 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HALLUCINATION, AUDITORY (medically significant), outcome "recovered", described as "She was hallucinating/having auditory hallucinations"; PYREXIA (non-serious), outcome "recovered", described as "She had a fever of 102.9"; HEADACHE (non-serious), outcome "unknown"; ABDOMINAL PAIN UPPER (non-serious), outcome "unknown", described as "pain in her stomach and in her side". The patient underwent the following laboratory tests and procedures: Body temperature: 102.9, notes: She had a fever of 102.9. Additional information: Reporter stated, "I am calling for (name withheld) (Patient). Well, I am calling to notify all the reaction that (name withheld) had so that the Pfizer Bivalent Vaccine (COVID-19 Bivalent Vaccine) that she received on 15Aug2023. A night she had a fever of 102.9. She was hallucinating, having auditory hallucinations and she had a headache and she started having stomach pain. Pain in her stomach, yes and in her side, normal side you know, but yeah. The fever lasted two days, might have lasted three days, but she got the day off and it lasted three days. I do not need any help. I do not need any help. I just want to let you know what her side effects are. Her fever is down, she is feeling better, but that was verified and she was hallucinating. She haven't been currently hallucinating and she is not experiencing fever."  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
Pt rec'd vaccines below on 4/11/05. Pt's mom reported redness and swelling on 4/14 at site of inj left deltoid. Pt seen by Dr on 4/14/05.
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and gender. The reporter stated that, on an unspecified date, and unknown number of doses of LIQUID PEDVAXHIB (dose, lot#, expiration dates not provided) that were stored at 48 degrees F for 20 minutes, then exposed to 47 degrees for 9 minutes have been administered. No adverse effects were reported. Follow up information has been received on 22-JUL-2014 from a receptionist. The reporter stated there were two different lot numbers of LIQUID PEDVAXHIB that were included in the temperature excursion: Lot # J016188, expiration date: 02-OCT-2016 and lot # J015437, expiration date: 09-OCT-2016. The receptionist did not have any additional information to share with Merck. Follow-up information from the registered nurse who provided patients details. This report refers to a 6 month old infant patient. On 17-JUN-2014 the patient was vaccinated with a dose of LIQUID PEDVAXHIB lot# J016188, expiration date 02-OCT-2016, (dose and route were not reported) that was improperly stored. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information is not expected because follow up has been obtained.
Headache, Myalgia, Fever, NauseaVomiting, right arm hot to touch Narrative:
could not walk; This spontaneous case was reported by a consumer and describes the occurrence of GAIT INABILITY (could not walk) in a 68-year-old female patient who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     The patient's past medical history included Multiple sclerosis, Pain, Burning sensation NOS, Osteoarthritis, Numbness, Ache, Ankle fracture, Fall and Knee deformity NOS (Weak knees). Concurrent medical conditions included Weight gain (put on weight) and Balance impaired NOS. Concomitant products included PREGABALIN, MAGNESIUM CHLORIDE (SLO-MAG), MELOXICAM (MOLOXICAM) and FUROSEMIDE for an unknown indication.    On 09-Mar-2021, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 10-Mar-2021, the patient experienced GAIT INABILITY (could not walk). At the time of the report, GAIT INABILITY (could not walk) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.       No Treatments were reported.
Migraine, and for two - three days after the shot I had a rash where the shot was put into my body.
p/vax pt exp tenderness; redness & warmth which originated from fingers to shoulder; chills;seen by MD; therapy w/solu-medrol;zyrtec;pt Sx required medical intervention to prevent serious outcome
This spontaneous report as received from a physician refers to multiple patients of unknown age and gender. The patients were vaccinated with doses of ZOSTAVAX in October 2012. On 20-OCT-2012 the patient realized all the ZOSTAVAX vaccines had expiration dates of 05-OCT-2012 and they have been giving them to patients all month. It was unknown if any of the patients would get the ZOSTAVAX again, and the outcome of multiple patients receiving expired ZOSTAVAX vaccines were unknown. Attempts are being made to obtain additional identifying information to distinguish the individual patients mentioned in this report. Additional information will be provided if available.
Patient presented to the pharmacy with a red, sore, warm spot on her arm approximately 1-2 inches below where she states the vaccine was administed. Vaccine administered on 8/27/2019 and pt presented on 9/1/2018. Patient states that she doesn't believe anything else could have caused the reaction. Advised patient to monitor and use a cold compress on the area and take OTC pain relievers if needed. Advised patient to monitor the spot and call the pharmacy or her PCP if the area does not improve or worsens.
This spontaneous report as received from an office manager refers to unspecified patients of unknown age and gender. No information regarding the patients' pertinent medical histories, drug reactions or allergies and concomitant therapies was provided. On unspecified dates beginning "sometime in June 2017", the patients were vaccinated with improperly stored doses of VAQTA lot # N005796, expiry date 26-MAY-2018; lot # N008823, expiry date 26-MAY-2018; lot # N005274, expiry date 03-APR-2018, orally (dose was not reported). No symptoms were reported. Administered doses of vaccines experienced the temperature excursion of 32 degrees Fahrenheit to 35 degrees Fahrenheit for 17 hours. Data logger was involved. There were no previous excursions reported. This is one of two reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1708USA003990:
Symptoms: fatigue, shortness of breath, high heart rate, confusion/cloudy head, aches, chest pain, burping, diarrhea.  Treatment: probiotics, Nexium, inhaler, hydration
This spontaneous report was received from a healthcare worker reporting a patient of unknown age and gender. On an unknown date, the patient was vaccinated by an unspecified nurse with an improperly stored M-M-R II lot # J016232, exp. 19/12/2015. Route, anatomical place and dose number were not provided. Concomitant therapies were not provided. At the time of the report, no adverse event was reported. The outcome was reported as unknown. Additional information is expected.
Mom states child had bloody stool Feb 27, 2014. 3/19/14 child went to hospital for vomiting and possible intussusception. 3/4/14 lethargic, no appetite, vomiting. Admitted to hospital had multiple ultrasounds to r/o intussusception.
Patient came to pharmacy on 08/09 at 09:15 to receive her 1st dose of covid vaccine. After the vaccine administration, patient started complaining of blurred vision and dizziness. Few min later, patient collapsed. Pharmacist was able to get her safely to the floor and in few min, she regained her consciousness. Staff made 911 call.Her legs got elevated to increase blood flow since her BP was reading at 103/74. About 5 min later, the paramedic team arrived and her care was taken over. Her vitals and BG looked normal. She was able to sit up after few min . However, she complained of having HA and syncope, the EMT team transferred her to hospital. Her family was informed about the incident.